[Protective activity of a bacterial plasmid, bearing the gene for the tick-borne encephalitis virus NS1 nonstructural...

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Tick-borne encephalitis (TBE) is a significant viral zoonosis transmitted by ticks.
• Current TBE vaccines primarily target the E structural protein.
• Developing alternative TBE vaccine strategies is crucial for disease control.

Purpose of the Study:

• To evaluate the efficacy of a DNA vaccine encoding the NS1 nonstructural protein of TBE virus.
• To assess the immune response generated by the NS1-based TBE vaccine in a mouse model.

Main Methods:

• Balb/c mice were immunized with three intramuscular injections of bacterial plasmid pMV45 (50 micrograms each) carrying the NS1 gene.
• Mice were subsequently challenged with a lethal dose of TBE virus.
• Antibody responses against NS1 and E proteins were analyzed post-challenge.

Main Results:

• The NS1 DNA vaccine conferred 88% protection against lethal TBE virus challenge.
• Humoral immunity against the NS1 protein was detected in vaccinated and challenged mice.
• Absence of antibodies to the E structural protein suggested a lack of manifest infection in protected mice.

Conclusions:

• The NS1 nonstructural protein of TBE virus is a viable target for vaccine development.
• A plasmid-based vaccine encoding NS1 demonstrates significant protective efficacy against TBE virus.
• This study highlights a novel approach for TBE vaccine design, potentially offering an alternative to existing E protein-based vaccines.